We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLU icon
2301
State Street Utilities Select Sector SPDR ETF
XLU
$22.8B
$1.21M ﹤0.01%
34,600
-317,958
-90% -$11.5M
FXLV
2302
DELISTED
F45 Training Holdings Inc.
FXLV
$1.21M ﹤0.01%
+308,756
New +$2.26M
XM
2303
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$1.21M ﹤0.01%
+96,836
New +$1.72M
FRXB.WS
2304
CALL
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$1.21M ﹤0.01%
123,581
DSX icon
2305
Diana Shipping
DSX
$292M
$1.21M ﹤0.01%
+316,132
New +$1.33M
THWWW
2306
CALL
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$1.2M ﹤0.01%
210,000
+3,800
+2% +$1.76K
ERII icon
2307
Energy Recovery
ERII
$400M
$1.2M ﹤0.01%
61,643
+40,588
+193% +$787K
XLP icon
2308
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
$1.2M ﹤0.01%
16,600
-306,212
-95% -$23M
MUB icon
2309
iShares National Muni Bond ETF
MUB
$45.9B
$1.2M ﹤0.01%
11,260
-17,904
-61% -$1.91M
STC icon
2310
Stewart Information Services
STC
$2.01B
$1.19M ﹤0.01%
24,011
+20,171
+525% +$1.08M
TCN
2311
DELISTED
Tricon Residential Inc.
TCN
$1.19M ﹤0.01%
+117,506
New +$1.51M
DCGOW
2312
CALL
DELISTED
DocGo Inc. Warrants
DCGOW
$1.19M ﹤0.01%
166,666
APOG icon
2313
Apogee Enterprises
APOG
$891M
$1.19M ﹤0.01%
30,250
-23,906
-44% -$1.02M
PAC icon
2314
Grupo Aeroportuario del Pacifico
PAC
$12.7B
$1.18M ﹤0.01%
8,473
-23,223
-73% -$3.41M
WPCA.WS
2315
CALL
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$1.18M ﹤0.01%
120,420
JUGGW
2316
CALL
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$1.18M ﹤0.01%
121,124
CWAN
2317
DELISTED
Clearwater Analytics
CWAN
$1.18M ﹤0.01%
+97,963
New +$1.58M
NBP
2318
NovaBridge Biosciences American Depositary Shares
NBP
$215M
$1.18M ﹤0.01%
+104,478
New +$1.25M
BAK icon
2319
Braskem
BAK
$881M
$1.18M ﹤0.01%
+82,528
New +$1.41M
IIIN icon
2320
Insteel Industries
IIIN
$629M
$1.18M ﹤0.01%
+35,015
New +$1.39M
FVT.WS
2321
CALL
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$1.18M ﹤0.01%
119,995
TSM icon
2322
PUT
TSMC
TSM
$2.23T
$1.18M ﹤0.01%
14,400
-3,000
-17% -$277K
SOAR.WS
2323
CALL
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$1.18M ﹤0.01%
118,929
BTAI icon
2324
BioXcel Therapeutics
BTAI
$32.4M
$1.17M ﹤0.01%
+5,553
New +$1.17M
MCRB icon
2325
Seres Therapeutics
MCRB
$46.6M
$1.17M ﹤0.01%
+17,045
New +$1.47M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.